LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $42,346,000 | -7.1% | 309,254 | -7.7% | 0.63% | -6.1% |
| Q3 2017 | $45,599,000 | +29.1% | 334,919 | +15.1% | 0.67% | +33.7% |
| Q2 2017 | $35,332,000 | +253.5% | 291,037 | +208.2% | 0.50% | +260.0% |
| Q1 2017 | $9,995,000 | +11.0% | 94,431 | +6.6% | 0.14% | +11.1% |
| Q4 2016 | $9,002,000 | -28.6% | 88,597 | -28.3% | 0.13% | -23.6% |
| Q3 2016 | $12,614,000 | -47.7% | 123,594 | -38.9% | 0.16% | -41.1% |
| Q2 2016 | $24,133,000 | +42.6% | 202,341 | +28.0% | 0.28% | +53.8% |
| Q1 2016 | $16,924,000 | – | 158,034 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |